CurrentBlue Cross Blue Shield - Rhode IslandPolicy N/A

Magnetic Capsule Endoscopy (MCE)

Policy governs coverage determination for magnetically controlled capsule endoscopy (NaviCam-type systems) for evaluation of gastrointestinal disorders, addressing Medicare Advantage and commercial products; excludes wireless capsule endoscopy. It specifies noncoverage / not medically necessary determinations and lists the not-covered CPT Category III code.

Policy Summary

PayerBlue Cross Blue Shield - Rhode Island

PolicyMagnetic Capsule Endoscopy (MCE)

Policy CodePolicy N/A

Change TypeClarified scope to magnetic capsule endoscopy only

Effective DateJun 1, 2022

Next Review Date

Key ActionClaims submitted for CPT code 0651T (magnetically controlled capsule endoscopy) are not covered for Medicare Advantage and are considered not medically necessary for Commercial Products and may be denied/rejected.

SourceLink

POLICY UPDATE CHANGES

Policy addresses magnetic capsule endoscopy only and does not address wireless capsule endoscopy.

1Not-covered CPT codes listed

2Plan types with noncoverage language

6Device contraindications listed

Coverage Summary

Scope: This policy governs coverage determinations for magnetically controlled capsule endoscopy (NaviCam-type systems) used to evaluate gastrointestinal disorders; it explicitly addresses magnetic capsule endoscopy only and excludes wireless capsule endoscopy. The policy applies to Medicare Advantage and Commercial products and lists the CPT Category III code 0651T as not covered / not medically necessary.

Coverage stance and evidence conclusion: Magnetic capsule endoscopy is designated as not covered / not medically necessary for Medicare Advantage and Commercial Plans because the evidence is considered insufficient to show an improvement in net health outcome for unexplained upper abdominal complaints or other indications. The policy notes 6 device contraindications in labeling (e.g., GI obstruction/stenosis/fistula, dysphagia, pacemakers/implantable electronic devices, pregnancy, age <22 years, BMI ≥38).

Medical Necessity / Coverage Determinations

Medicare Advantage Plans - Coverage Determination

Magnetic capsule endoscopy is not covered when used for the evaluation of the following:

ANY of the following

Unexplained upper abdominal complaints
All other indications (any use beyond excluded indication)

Code not covered: CPT 0651T (Magnetically controlled capsule endoscopy) is not covered for Medicare Advantage Plans

Commercial Products - Medical Necessity Determination

Magnetic capsule endoscopy is considered not medically necessary when used for the evaluation of the following:

ANY of the following

Unexplained upper abdominal complaints
All other indications (any use beyond excluded indication)

Code not medically necessary: CPT 0651T (Magnetically controlled capsule endoscopy) is considered not medically necessary for Commercial Products

Contraindications / Patient Exclusions (Device labeling information)

Device contraindications noted in policy (informational; not listed as coverage exceptions):

Contraindications / Patient Exclusions

Gastrointestinal obstruction/stenosis/fistula: Patients with gastrointestinal obstruction, stenosis, or fistula
Dysphagia: Patients with dysphagia
Implantable electronic devices: Patients with cardiac pacemakers or other implantable electronic medical devices
Pregnancy: Pregnant women

Provider Actions & Billing Impact

Denial Risk

Claims for magnetic capsule endoscopy will be denied / not paid

Claims submitted for CPT code 0651T (magnetically controlled capsule endoscopy) are not covered for Medicare Advantage and are considered not medically necessary for Commercial Products and may be denied/rejected.

0651T

Documentation Required

Benefit and eligibility confirmation

Providers must refer to the member's Benefit Booklet, Evidence of Coverage or Subscriber Agreement for applicable benefits and eligibility, as coverage may vary between groups and contracts.

Check the member's Benefit Booklet / Evidence of Coverage / Subscriber Agreement for applicable benefits and eligibility.

Background & Evidence Summary

Magnetically maneuvered capsule endoscopy (e.g., NaviCam) is an FDA-approved system that uses a single-use ingestible capsule plus an external magnet and physician-operated console to control capsule motion and visualize the stomach and esophagus; it is noninvasive, does not require sedation, and typically completes in about 15–20 minutes with the capsule expelled within about 24 hours on average.

Procedure characteristics and evidence summary: Studies comparing magnetic capsule endoscopy with conventional gastroscopy have generally found similar diagnostic accuracy, sensitivity, and specificity, with increased patient preference and an acceptable safety profile, but the diagnostic characteristics are currently inadequate to substitute for other modalities and there is insufficient direct evidence that magnetic capsule endoscopy improves patient health outcomes.

Evidence & definition

RegulatoryFDA approval of NaviCam system in May 2020

Evidence conclusionInsufficient evidence that magnetic capsule endoscopy improves net health outcome for unexplained upper abdominal complaints or other indications

Definition (MCE)A magnetically maneuvered ingestible capsule system that captures wireless images of the GI tract and is controlled by an external magnet/console to visualize the stomach and esophagus.

Diagnostic findingsStudies show diagnostic accuracy similar to gastroscopy but inadequate to substitute for or triage to other modalities

Procedure characteristicsNoninvasive, no sedation, ~15-20 minute procedure; single-use ingestible capsule with operator-controlled external magnet/console

Revision History

Clarified

Statement explicitly limits policy scope to magnetic capsule endoscopy. Policy addresses magnetic capsule endoscopy only and does not address wireless capsule endoscopy.

2022-06-01Policy effective

Effective date of the policy.

2025-01-22Last review

Most recent policy review date.